Division of Laryngology and Broncho-esophagology, Department of Otolaryngology-Head Neck Surgery, UMONS Research Institute for Health Sciences and Technology, EpiCURA Hospital, University of Mons (UMons), Mons, Belgium.
Department of Otorhinolaryngology and Head and Neck Surgery, School of Medicine, Foch Hospital, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France.
Eur Arch Otorhinolaryngol. 2024 Nov;281(11):5841-5846. doi: 10.1007/s00405-024-08816-5. Epub 2024 Jul 11.
To investigate the platelet-rich plasma (PRP) effectiveness in patients with a long-lasting postviral olfactory dysfunction (LPOD).
Forty-three consecutive patients with a long-lasting postviral OD were prospectively recruited. The injection of 1 mL of PRP was carried out in both olfactory clefts. The pre- to 6-month post-PRP injection change in olfaction was assessed with the olfactory disorder questionnaire (ODQ) and the threshold, discrimination, and identification (TDI) tests.
Forty-three patients received bilateral PRP injections (24 females). The mean age of patients was 58.9 ± 16.8 years. The mean duration of LPOD was 8.7 years. The pre to 6-month post-injection mean TDI significantly improved from 10.3 ± 10.2 to 20.12 ± 12.07 (p = 0.001). The mean ODQ significantly decreased from 29.8 ± 13.0 to 23.4 ± 11.3 (p = 0.013). The average change of the TDI and the ODQ were 9.8 and 6.4, respectively. Age was inversely associated with the 6-month threshold score.
PRP appears to be a promising therapeutic strategy for long-lasting postviral OD. Our findings support the conduction of controlled randomized trial in this population of patients.
研究富血小板血浆(PRP)治疗持续性病毒后嗅觉障碍(LPOD)的效果。
前瞻性招募 43 例持续性病毒后嗅觉障碍患者。在两个嗅裂中注射 1 毫升 PRP。使用嗅觉障碍问卷(ODQ)和阈值、辨别和识别(TDI)测试评估 PRP 注射前至 6 个月的嗅觉变化。
43 例患者接受了双侧 PRP 注射(24 例女性)。患者的平均年龄为 58.9±16.8 岁。LPOD 的平均持续时间为 8.7 年。注射前至 6 个月的 TDI 均值从 10.3±10.2 显著改善至 20.12±12.07(p=0.001)。ODQ 均值从 29.8±13.0 显著降低至 23.4±11.3(p=0.013)。TDI 和 ODQ 的平均变化分别为 9.8 和 6.4。年龄与 6 个月阈值评分呈负相关。
PRP 似乎是治疗持续性病毒后嗅觉障碍的一种有前途的治疗策略。我们的研究结果支持在该患者群体中进行对照随机试验。